Insider Transactions in Q4 2023 at Aerovate Therapeutics, Inc. (AVTE)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
125
-3.7%
|
$3,000
$24.5 P/Share
|
|
Dec 27
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
125
+3.57%
|
$250
$2.14 P/Share
|
|
Dec 20
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-55.16%
|
$76,000
$19.5 P/Share
|
|
Dec 14
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,897
-75.27%
|
$188,043
$19.5 P/Share
|
|
Dec 14
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,897
+42.95%
|
$9,897
$1.74 P/Share
|
|
Dec 13
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,103
+31.88%
|
$6,103
$1.74 P/Share
|
|
Dec 13
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,103
-39.28%
|
$39,957
$19.5 P/Share
|
|
Dec 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,283
-88.85%
|
$164,528
$16.11 P/Share
|
|
Dec 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,283
+39.96%
|
$10,283
$1.94 P/Share
|
|
Dec 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
4,600
-74.09%
|
$73,600
$16.3 P/Share
|
|
Dec 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+32.88%
|
$4,600
$1.94 P/Share
|
|
Nov 27
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
12,517
-90.65%
|
$200,272
$16.24 P/Share
|
|
Nov 27
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
12,517
+40.85%
|
$12,517
$1.94 P/Share
|
|
Nov 24
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
4,990
-41.74%
|
$74,850
$15.91 P/Share
|
|
Nov 24
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
4,990
+44.27%
|
$9,980
$2.14 P/Share
|
|
Nov 22
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
13,800
-89.56%
|
$207,000
$15.0 P/Share
|
|
Nov 22
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,800
+40.17%
|
$13,800
$1.94 P/Share
|
|
Nov 22
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
9,382
-87.9%
|
$140,730
$15.17 P/Share
|
|
Nov 22
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
9,382
+39.47%
|
$9,382
$1.94 P/Share
|
|
Nov 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,092
-100.0%
|
$10,920
$10.42 P/Share
|
|
Nov 01
2023
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
970
-100.0%
|
$9,700
$10.46 P/Share
|